Rojo-Gutiérrez, Rocío Patricia

Dr. Rocío Patricia Rojo Gutiérrez graduated first in her Biotechnology Engineering class from the Technological Institute of Sonora in 2008. Subsequently, in 2010 she completed a Master of Science with a specialty in Biotechnology at Tecnológico de Monterrey, where her thesis project focused on Cell Therapy. In 2013, she started a Ph.D. in Developmental Biology at the Roslin Institute, University of Edinburgh, UK. There, she carried out projects related to immunological studies, for which she developed a variety of cell and animal models that were genetically modified. In 2018 she rejoined the School of Medicine and Health Sciences (EMCS) of Tecnológico de Monterrey, and through her postdoctoral stay she collaborated in projects aimed to validate biomarkers potentially relevant to both cancer and metabolic diseases. Since 2022, Dr. Rojo has been a Research Professor at the EMCS, Querétaro Campus. She is a Professor of the Graduate Program in Biosciences (M.Sc. and Ph.D.) and has been invited by the School of Engineering and Sciences of Tec de Monterrey to participate as a Guest Professor in subjects related to Biotechnology and Biomedicine. As well she is part of the liaison program between PrepaTec and the professional education area of the EMCS, Querétaro. Dr. Rojo received was recognized for the academic quality of her lectures (results of the student opinion survey in the August-December 2019 semester). In research, Dr. Rocío Rojo is a member of the National System of Researchers Level 1, has 16 publications in indexed journals, including a first authorship in Nature Communications, has more than 450 citations, an h index of 10, and the animal models she has developed and characterized are part of the Jackson Laboratories catalogue. Dr. Rojo works under an interdisciplinary approach, combining developmental biology, biotechnology and biomedicine to study molecular effectors and signals that are involved in the disruption of homeostasis associated with senescence and systemic pathologies such as metabolic disorders and cancer.